New hope for liver cancer patients when first treatment stops working
Disease control
Recruiting now
This study is for people with advanced liver cancer that cannot be removed by surgery and has continued to grow despite their first treatment. Researchers want to see if continuing one of the original drugs (atezolizumab) alongside a new type of drug (cabozantinib or lenvatinib) …
Phase: PHASE2 • Sponsor: Academic and Community Cancer Research United • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC